Sekhmet Ventures

Barbara Paldus leads investment decisions. She founded the firm, drawing on her own experience taking Finesse Solutions from startup to acquisition by Thermo Fisher Scientific in 2017. No separate investment committee is disclosed on the firm’s website.

Yes. The firm gives portfolio companies access to its in-house distribution arm, which manages global logistics, retailer relationships, and shelf placement. Sekhmet also supplies digital marketing, manufacturing sourcing, and regulatory compliance support — services it frames as a way to accelerate growth without additional equity dilution.

Sekhmet targets early-stage, science-based beauty and wellness brands with ultra-pure, 100%-natural product lines. Its portfolio disclosed on the website includes Terasana Clinical, a clinical-grade skincare brand, and it previously handled distribution for Costa Brazil before that brand was acquired by Amyris in June 2021.

It is a venture capital firm structured as an asset manager. The principals — Paldus, Farmwald, and Kaur — sit together at Skymoon Ventures, suggesting overlapping LP relationships, but Sekhmet operates as an independent private equity vehicle rather than a family office.

The distribution arm operates as a separate entity under the Sekhmet umbrella. It buys inventory from portfolio companies and places products with global retailers, but Sekhmet has not publicly disclosed whether this is a for-profit standalone business, a cost-plus operation, or a subsidized service. The distinction matters because it affects how much revenue flow portfolio founders retain.

Sekhmet’s website states that the distribution arm places beauty and wellness products worldwide, specifically naming distribution activity in Asia, Europe, and North America. The span across these regulated markets implies the team holds deep regulatory-approval expertise in jurisdictions like the EU and South Korea.

No. Sekhmet has not published AUM, fund size, or capital-deployment figures. Outside allocators considering co-investment should treat the firm’s scale as unmapped absent direct confirmation from the principals.